Case report reveals sudomotor dysfunction in a man with Harlequin syndrome after COVID-19 infection, suggesting neurogenic tumor involvement.
Harlequin syndrome (HS) is a rare neurological disorder characterised by segmental anhidrosis and contralateral compensatory flushing, typically involving the face and extending to the neck. A 44‐year‐old man developed flushing of the right hemiface accompanied by left‐sided anhidrosis affecting the face, neck, upper chest and upper extremity 4 months after infection with severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) infection. Although idiopathic anhidrosis associated with SARS‐CoV‐2 infection was initially suspected, imaging studies revealed a 43‐mm mass adjacent to the left T2–T3 intervertebral foramen. Progressive tumour enlargement paralleled worsening sudomotor dysfunction, leading to a diagnosis of symptomatic HS secondary to a presumed neurogenic tumour. Disruption of the sympathetic pathway at the T2–T3 level resulted in anhidrosis extending into the face beyond the corresponding sensory dermatomes. Magnetic resonance imaging and/or computed tomography are particularly useful for diagnostic evaluation of HS; however, the extent of imaging should be determined by the attending physician based on an understanding of the distribution of the sympathetic pathways.
No takes yet. Share an insight, caveat, or question.
Baba et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: